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THE phorboldiester, 12-0-tetradecanoyl-
phorbol-13-acetate (TPA) and various
other tumour promoters affect cells in
culture at various levels and in a variety
of ways (Slaga et al., 1978). It is now
increasingly appreciated that tumour pro-
moters can affect mononuclear phago-
cytes at different levels and with opposite
consequences: (1) precursors of the mono-
nuclear phagocyte lineage are selectively
stimulated to proliferate and differentiate
into macrophages, thus mimicking the
effects of macrophage colony-stimulating
activity (Stuart & Hamilton, 1980; Keller
& Keist, submitted for publication); (2)
spontaneous cytolytic activity expressed
by macrophages and by "natural killer"
(NK) cells is suppressed (Keller, 1979);
(3) the capacity of induced, activated
macrophages to manifest immunologically
non-specific cytotoxicity against a large
array of tumour targets is clearly reduced
(Keller, 1979); and (4) interaction of
activated macrophages with TPA triggers
the killing of target cells susceptible to
H202 (Nathan et al., 1979). In showing
that lymphokine-induced macrophage
activation is effectively suppressed by
TPA and various other tumour promoters,
the present work provides further evidence
for the manifold and often ambiguous
effects of these agents.
Peritoneal wash-outs from normal DA
rats or C3H/J mice were seeded into
35 mm plastic Petri dishes and incubated
for 2 h at 37°C. After intensive washing,
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the cells remaining adherent were used as
a source of effector cells (Keller, 1978). To
enhance their non-specific cytolysis the
resting adherent peritoneal cells were
interacted for 8 h with macrophage-
activating lymphokines (MAL; a cell-free
supernatant from 72h cultures of rat
spleen cells in serum-free RPMI-1640
medium supplemented with 5 Hg/ml con-
canavalin A (Sigma); final concentration
20%) and then washed. DA rat polyoma-
induced tumour cells (Keller, 1978) were
used as target cells, having been pre-
labelled with [14C]-dT (methyl-14C-dT
40-60 mCi/mmol; New England Nuclear,
Boston, Mass.) as previously described
(Keller & Keist, 1978) and then inter-
acted with effector cells for 36 h at 37°C
(initial effector/target cell ratio 10: 1).
The released radioactivity was then meas-
ured and net cytotoxicity calculated
(Keller, 1978).
The results with rat effector cells,
presented in the Table, show that the
phorbol esters TPA (Hecker, 1978) and
phorbol-12,13-didecanoate (PDD; Hecker,
1978) as well as the loa-alkyldaphnane,
Pimelea factor P2 (Zayed et al., 1977) in a
final concentration of 10-8M, are com-
parably active in suppressing spontaneous
and in preventing lymphokine-induced
enhancement of macrophage tumoricidal
activity. It is noteworthy that manifesta-
tion of spontaneous macrophage cyto-
toxicity was similarly inhibited whether
effector cells were first pretreated for 4 hTPA PREVENTS MACROPHAGE ACTIVATION
TABLE.-Tumour promoters suppress spontaneous and prevent lymphokine-induced
enhancement of cytotoxicity manifested by adherent rat peritoneal cells
Tumour promoter
Exp. (TP) (10-8M)
I {TPA phorbol
2 {PDD 3 4-PDD
3 P2
Without further treatment
of effector cells
, ~~~A-
TP present during
Alone 36h effector phase
15+6 6+4*
15+6 16+7
13+4 4+3*
13+4 15+6
21+4 7+5*
After 8h interaction
with lymphokines
Alones
46+8
46+8
55+6
55+6
61+ 10
TP present during 8h
interaction with lymphokines
19+7*
48+9
12 + 4*
52+7
28+8*
Adherent DA rat peritoneal cells were interacted for 36 h at an effector/target-cell ratio of 10:1 with
polyoma-induced DA rat tumour cells Py-12 (Keller, 1973) and cytotoxicity assessed with the [14C]-dT-
release assay (Keller & Keist, 1978). Results represent the mean + s.d. %O net isotope release from 6 cultures
each. *These values are significantly different (P < 0 -001; t test) from controls.
with tumour promoters and the washed
effector cells then interacted with pre-
labelled targets (not shown) or whether
the promoting agents were present
throughout the 36 h effector/target-cell
interaction (Table). Enhancement by
lymphokines of macrophage-mediated
long-term cytotoxicity wassimilarly abrog-
ated when tumour promoters were present
only during the 8h activation (Table) or
only during the effector/target-cell inter-
action. Similar results were obtained with
effector cells derived from C3H/J mice.
In addition to the earlier evidence that
manifestation of cytotoxicity by NK cells
and by resting and previously activated
macrophages is markedly suppressed by
tumour promoters (Keller, 1979) the
present work attests to the ability of
active promoters of the phorbol diester-
and daphnane-type to prevent lympho-
kine-induced enhancement of macrophage
cytolysis. In showing that agents with
different structure but comparably potent
tumour-promoting activity in mouse skin
(such as the phorbol esters TPA and PDD
and the lo-alkyldaphnane Pimelea factor
P2) are similarly active in suppressing the
activation for and the manifestation of
cytotoxicity by rat and mouse macro-
phages, the present findings suggest that
this capacity may be common to all
tumour promoters. Such a conclusion is
further supported by the present and
earlier (Keller, 1979) demonstration that
10*
agents structurally closely related to the
active phorbol esters but without tumour-
promoting activity, such as phorbol
(Hecker & Schmidt, 1974) and 4a-phorbol-
12,13-didecanoate (4cx-PDD; Hecker,
1978), were inactive in this experimental
model.
The mechanism by which acquisition
and manifestation of cytotoxicity by
macrophages is affected, is still far from
being understood. This is not surprising
in view of the various possible mechan-
isms for the mediation of immunologic-
ally non-specific macrophage cytotoxicity
(Keller, 1981) and the diversity of effects
exerted by tumour promoters on cells in
culture (Slaga et al., 1978; Keller, 1979;
Nathan et al., 1979; Stuart & Hamilton,
1980; Keller & Keist submitted). How-
ever, there is varied rather conclusive
evidence that in the concentration used,
tumour promoters do not impair the
function of effector and target cells. This
conclusion is supported by numerous
observations attesting to the capacity of
tumour promoters to induce or enhance in
various cell types a variety of functions.
In mononuclear phagocytes, these agents
are able, among many other things, to
induce proliferation and differentiation in
marrow precursors and to trigger in
activated macrophages H202-mediated
short-term cytotoxicity. Together with
earlier work, the present findings lend
further support to the concept that
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tumour promoters facilitate the out-
growth of transformed cells by two major
mechanisms: (1) the stimulation of their
multiplication and functional capacities
and (2) the suppression of the host's
cellular antitumour effector systems.
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